Following Solar Debacle, Republicans Come Out Swinging on China
The Republican-led China Task Force held an impromptu meeting Wednesday, where they backed stronger export and capital controls if they win back the House.
U.S. Trade Deficit Eases in April, Down 19.1% to $87.1 Billion
The trade deficit fell. But the January-April goods deficit is still another record breaker.
Biden Just Went Against His Voters, Sided with China on Solar
Voters support locally made solar. So why is the Biden administration giving China companies under investigation for trade violations in SE Asia duty-free access to the U.S.?
Leading Customs Authorities Make The Case Against De Minimis Commerce
Leading customs authorities make the case against de minimis commerce By Charles Benoit, CPA Trade Counsel “De minimis” treatment for imports, which is available if
FDA’s Updated Drug Shortage List Loaded with Critical Medicines
The Food and Drug Administration recently updated its drug shortage list. More than half of the updates include drugs on the essential medicines list.
Senate Republicans Want to Give Geneva a Leash to Heel U.S. Presidency
Senate Republicans, led by Mike Crapo, are willing to give the WTO more power over U.S. trade than the White House.
How Trade Remedies Helped U.S. Manufacturers
Solar and steel tariffs helped the industry expand. Here is where the naysayers were wrong about rising prices and market destruction due to anti-dumping charges and other trade remedies.
Pharma and Trade Deals Top of Mind in China Commission Hearing
The U.S. China Economic and Security Review Commission discussed the tight-linked China-India pharmaceutical supply chain, and tossed aside the notion that sweeping trade deals with India and the region are good ideas.
Senate Intelligence Hearing on China: “Run Faster and Slow Them Down.”
The Senate Intelligence Committee discusses China’s strategy for economic and technological dominance. Senator Marco Rubio wonders if China will hold supply chains hostage.
FDA Funding Bill Heads to Final Committee, With One Major Stumbling Block
The Health subcommittee of the House Energy and Commerce Committee have moved the FDA user-fee reauthorization bill to final committee. Chairwoman Eshoo says it is on track for September approval.
